ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraaknorsk 
    • EnglishEnglish
    • norsknorsk
  • Administrasjon/UB
Vis innførsel 
  •   Hjem
  • Universitetsbiblioteket
  • Artikler, rapporter og annet (UB)
  • Vis innførsel
  •   Hjem
  • Universitetsbiblioteket
  • Artikler, rapporter og annet (UB)
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer

Permanent lenke
https://hdl.handle.net/10037/25057
DOI
https://doi.org/10.1038/bjc.2012.471
Thumbnail
Åpne
article.pdf (345.7Kb)
Publisert versjon (PDF)
Dato
2012-11-20
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Forfatter
Brydøy, Marianne; Fosså, Sophie Dorothea; Klepp, Olbjørn; Bremnes, Roy M.; Wist, Erik; Bjøro, Trine; Wentzel-Larsen, Tore; Dahl, Olav
Sammendrag
Background: The objective of this study was to assess markers of spermatogenesis in long-term survivors of testicular cancer (TC) according to treatment, and to explore correlations between the markers and associations with achieved paternity following TC treatment.

Methods: In 1191 TC survivors diagnosed between 1980 and 1994, serum-follicle stimulating hormone (s-FSH; n ¼ 1191), s-inhibin B (n ¼ 441), and sperm counts (millions per ml; n ¼ 342) were analysed in a national follow-up study in 1998–2002. Paternity was assessed by a questionnaire.

Results: At median 11 years follow-up, 44% had oligo- (o15 millions per ml; 29%) or azoospermia (15%). Sperm counts and s-inhibin B were significantly lower and s-FSH was higher after chemotherapy, but not after radiotherapy (RT), when compared with surgery only. All measures were significantly more abnormal following high doses of chemotherapy (cisplatin (Cis)4850 mg, absolute cumulative dose) compared with lower doses (Cis p850 mg). Sperm counts were moderately correlated with s-FSH ( 0.500), s-inhibin B (0.455), and s-inhibin B : FSH ratio ( 0.524; all Po0.001). All markers differed significantly between those who had achieved post-treatment fatherhood and those with unsuccessful attempts.

Conclusion: The RT had no long-term effects on the assessed markers of spermatogenesis, whereas chemotherapy had. At present, the routine evaluation of s-inhibin B adds little in the initial fertility evaluation of TC survivors

Sitering
Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist E, Bjøro T, Wentzel-Larsen T, Dahl O. Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. British Journal of Cancer. 2012;107(11):1833-1839
Metadata
Vis full innførsel
Samlinger
  • Artikler, rapporter og annet (UB) [3251]
Copyright 2012 Cancer Research UK

Bla

Bla i hele MuninEnheter og samlingerForfatterlisteTittelDatoBla i denne samlingenForfatterlisteTittelDato
Logg inn

Statistikk

Antall visninger
UiT

Munin bygger på DSpace

UiT Norges Arktiske Universitet
Universitetsbiblioteket
uit.no/ub - munin@ub.uit.no

Tilgjengelighetserklæring